Optima Health plc (AIM:OPT)

London · Delayed Price · Currency is GBP · Price in GBX

192.00

-1.50 (-0.78%)

At close: Apr 27, 2026

5.21% (1Y)

Market Cap	208.85M
Revenue (ttm)	113.75M
Net Income (ttm)	3.53M
Shares Out	108.78M
EPS (ttm)	0.04
PE Ratio	49.76
Forward PE	14.95
Dividend	n/a
Ex-Dividend Date	n/a

Volume	59,233
Average Volume	126,368
Open	193.50
Previous Close	193.50
Day's Range	190.00 - 194.00
52-Week Range	177.00 - 233.00
Beta	n/a
RSI	69.30
Earnings Date	Jul 8, 2026

About Optima Health

Optima Health plc provides occupational health and wellbeing services for the public and private sectors in the United Kingdom. The company offers strategy and advisory services; risk and compliance services comprising health surveillance, pre-placement, fitness for work, immunizations, and pensions; performance and attendance services, including attendance and productivity management; engagement and wellbeing services through digital platforms, health assessments, and onsite activities; mental health services; and musculoskeletal health servic... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 1947

Employees 850

Stock Exchange London Stock Exchange AIM

Ticker Symbol OPT

Full Company Profile

Financial Performance

Financial Statements

News

Optima Health Earnings Call Transcript: H1 2026

Revenue grew 17% to GBP 59.5 million in H1 2026, driven by acquisitions and organic growth, with strong new business wins and robust cash generation. Strategic initiatives and transformation programs are underway to boost margins and reach medium-term targets, supported by a stable competitive landscape.

4 months ago - Transcripts

Optima Health Earnings Call Transcript: H2 2025

FY 2025 saw revenue dip to GBP 105 million due to contract changes, but underlying growth was 4.1% and EBITDA margin improved to 16.7%. Net debt dropped sharply post-demerger, and record new business wins, including a major UK Armed Forces contract, position the company for strong future growth.

10 months ago - Transcripts

Optima Health Earnings Call Transcript: H1 2025

Reported resilient H1 FY2025 results with £50.8m revenue and 17% EBITDA margin, despite prior contract losses. New business wins and a strong pipeline support 4% organic growth, while net debt fell to £0.6m. Margin expansion and further growth are targeted as integration and restructuring are complete.

1 year ago - Transcripts